Key facts
- Xandar Kardian’s last known valuation is $31.0M (Dec 2021).
- It has raised $28.6M; the latest was Later Stage VC ($25.0M) in Feb 2026.
- Notable investors include Matter (Consulting Services (B2B)), SBVA, CABHI, Phoenix Venture Partners, Palo Alto Capital — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Xandar Kardian
- ·The full record, as it builds
Funding rounds
No funding rounds for Xandar Kardian are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xandar Kardian
Developer of a radar-based sensing platform designed to monitor human presence, motion, and vital signs for security, cleantech, and healthcare use. The company offers end-to-end digital radar signal processing, contactless monitoring of heart rate and breathing, and occupant location tracking, enabling building operators, healthcare providers, and safety-focused organizations to gain continuous physiological and motion insights without wearables.
- Industry
- Healthcare
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 39
- Website
- xkcorp.com/
- Ownership
- Privately Held (backing)
Xandar Kardian doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xandar Kardian shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xandar Kardian in its N-PORT filings yet. We sweep new filings monthly.